- A National Institutes of Health (NIH) trial involving more than 1,000 patients revealed that remdesivir can help COVID-19 patients recover faster.
- Dr. Anthony Fauci said that the drug will become the standard of care for the novel coronavirus disease.
- The study hasn’t been published or peer-reviewed and some questions still remain, but the early results seem very promising.
- Visit BGR’s homepage for more stories.
We’ve been talking about remdesivir for quite a while since the novel coronavirus pandemic started. It’s one of the proposed COVID-19 therapies that’s been used in all sorts of trials around the world, a drug that has been initially developed to fight the Ebola virus. In the past few days, we saw remdesivir studies that delivered not-so-great news, but also leaked research that revealed the drug is quite promising at treating some COVID-19 patients. But it was Dr. Anthony Fauci who gave the biggest remdesivir endorsement on Wednesday. The drug is good news for COVID-19 patients and will become the standard of care in the US, where a study delivered relevant data about the drug’s effectiveness against the novel virus. However, it’s not all good news, as the drug might not be able to reduce the mortality rate.
Today’s Top Deals
- Amazon has a special page full of face masks ready to ship out now
- Today’s top deals: Face masks and hand sanitizer in stock, $8 Anker wireless charger, $33 webcam, $49 Instant Pot, more
- Anova’s hot new sous vide cookers are finally in stock at Amazon
Trending Right Now:
- Best Buy’s big sale is packed with great deals today – here’s our top 10
- Can’t get your stimulus check info? Try this simple fix
- This coronavirus vaccine might be just a few months away from release
Coronavirus medicine remdesivir just got its most important endorsement yet originally appeared on BGR.com on Thu, 30 Apr 2020 at 16:13:40 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report